SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-317667
Filing Date
2021-11-03
Accepted
2021-11-03 07:11:09
Documents
15
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d250499d8k.htm   iXBRL 8-K 29131
2 EX-99.1 d250499dex991.htm EX-99.1 601543
7 GRAPHIC g250499g1101080504898.jpg GRAPHIC 2073
  Complete submission text file 0001193125-21-317667.txt   843654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hznp-20211103.xsd EX-101.SCH 3240
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20211103_def.xml EX-101.DEF 13689
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20211103_lab.xml EX-101.LAB 22511
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20211103_pre.xml EX-101.PRE 14547
8 EXTRACTED XBRL INSTANCE DOCUMENT d250499d8k_htm.xml XML 5229
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 211373706
SIC: 2834 Pharmaceutical Preparations